Market Cap

Zymeworks Inc. Market Capitalization:

$2.02 Billion

USD as of Jan. 1, 2026

business Zymeworks Inc. Company Profile

Zymeworks Inc. Main Stock Listing

NYSE: ZYME

Market Capitalization History of Zymeworks Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Zymeworks Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2026 $2.02 B 97.51%
Jan. 1, 2025 $1.02 B 38.09%
Jan. 1, 2024 $739.2 M 17.34%
Jan. 1, 2023 $630.0 M 12.36%
Jan. 1, 2022 $560.7 M -73.68%
Jan. 1, 2021 $2.13 B -22.50%
Jan. 1, 2020 $2.75 B 173.95%
Jan. 1, 2019 $1.00 B 20.77%
Jan. 1, 2018 $830.9 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Zymeworks Inc. Categories

Canada languages Healthcare languages Biotechnology
Canada Healthcare Canada Biotechnology

Stocks & Indices

Zymeworks Inc. has the following listings and related stock indices.


Stock: NYSE: ZYME

Stock: FSX: 0OX

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.